Journal List > J Korean Rheum Assoc > v.16(3) > 1003672

Kim, Choi, Sung, Lee, and Bae: Characteristics of Korean Patients with RA: A Single Center Cohort Study

Abstract

Objective

The aim of this study is to describe the general characteristics and potential susceptibility genes of a large cohort of Korean rheumatoid arthritis (RA) patients.

Methods

After giving consent, the patients were invited to undergo a structured interview and clinical examination that were performed by rheumatologists and a specially trained research nurse. When appropriate, the information obtained by interview was supplemented by information from the patient's medical record. We reviewed the genetic studies for the subjects in the Hanyang RA cohort to investigate the genetic characteristics of Korean RA patients.

Results

The mean age of the Hanyang RA cohort was 51.6±12.4 years, and 88.1% were women. The unemployment rate was 19.6%, and 52.2% of the patients had limitation of everyday life or their work life. The mean age at the time of disease onset was 41.0±12.9 years and the duration from disease onset to initiation of treatment was 23.6±57.1 months. The smoking rate of the Hanyang RA cohort was 16.8%, and 30.8% of the patients were exposed to passive smoking. Total joint arthroplastys were performed in 158 (10.3%) patients, and the most common operation site was the knee. On the review of the genetic studies for the Hanyang RA cohort, the representative susceptibility genes for the development of RA were HLA-DRB1, PADI4, STAT4 and TRAF1-C5.

Conclusion

This data of Korean RA patients can be used as the preliminary data for important studies. Establishment of a large prospective, multicenter cohort is imperative to determine the characteristics of Korean RA, and the Hanyang RA cohort is expected to play a lead role for this.

References

1. Hur NW, Choi CB, Uhm WS, Bae SC. The Prevalence and Trend of Arthritis in Korea: Results from Korea National Health and Nutrition Examination Surveys. JKRA. 2008; 15:11–26.
crossref
2. Abdel-Nasser AM, Rasker JJ, Valkenburg HA. Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis. Semin Arthritis Rheum. 1997; 27:123–40.
crossref
3. Lee HS, Korman BD, Le JM, Kastner DL, Remmers EF, Gregersen PK, et al. Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations. Arthritis Rheum. 2009; 60:364–71.
crossref
4. Ravindran V, Seah MA, Elias DA, Choy EH, Scott DL, Gordon PA. Clinical and radiological features of rheumatoid arthritis in British black Africans. Clin Rheumatol. 2008; 27:97–100.
crossref
5. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31:315–24.
crossref
6. Bae SC, Cook EF, Kim SY. Psychometric evaluation of a Korean Health Assessment Questionnaire for clinical research. J Rheumatol. 1998; 25:1975–9.
7. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA. 1949; 140:659–62.
crossref
8. Lee HS, Lee KW, Song GG, Kim HA, Kim SY, Bae SC. Increased susceptibility to rheumatoid arthritis in Koreans heterozygous for HLA-DRB1∗0405 and ∗0901. Arthritis Rheum. 2004; 50:3468–75.
crossref
9. Kang CP, Lee HS, Ju H, Cho H, Kang C, Bae SC. A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum. 2006; 54:90–6.
10. Lee HS, Remmers EF, Le JM, Kastner DL, Bae SC, Gregersen PK. Association of STAT4 with rheumatoid arthritis in the Korean population. Mol Med. 2007; 13:455–60.
crossref
11. Han TU, Bang SY, Kang CW, Bae SC. TRAF1 polymorphisms associated with rheumatoid arthritis susceptibility in Asians and Caucasians. Arthritis Rheum. In press. 2009.
12. Young A. What have we learnt from early rheumatoid arthritis cohorts? Best Pract Res Clin Rheumatol. 2009; 23:3–12.
crossref
13. Singh G. Arthritis, rheumatism and aging medical information system postmarketing surveillance program. J Rheumatol. 2001; 28:1174–9.
14. Yamanaka H, Tohma S. Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice. Mod Rheumatol. 2006; 16:75–6.
crossref
15. Bengtsson C, Nordmark B, Klareskog L, Lundberg I, Alfredsson L. Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis. 2005; 64:1588–94.
16. Dadoniene J, Uhlig T, Stropuviene S, Venalis A, Boonen A, Kvien TK. Disease activity and health status in rheumatoid arthritis: a case-control comparison between Norway and Lithuania. Ann Rheum Dis. 2003; 62:231–5.
crossref
17. Albers JM, Paimela L, Kurki P, Eberhardt KB, Emery P, van't Hof MA, et al. Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis. Ann Rheum Dis. 2001; 60:453–8.
crossref
18. Park NG, Kim WK, Shin DH, Choi YM, Lee YJ, Song YW, et al. Prevalence of Osteoarthritis and Rheumatoid Arthritis in Two Communities in Korea. JKRA. 2003; 10:151–7.
19. Korea Center for DiseaseControl and Prevention, Korea Institute for Health and Social Affairs. Smoking. In-depth Analyses of the Third National Health and Nutrition Examination Survey: The Health Interview and Health Behavior Survey Part. 2007.
20. Costenbader KH, Chang SC, De Vivo I, Plenge R, Karlson EW. Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking. Arthritis Res Ther. 2008; 10:52R.
crossref
21. Rupp I, Boshuizen HC, Roorda LD, Dinant HJ, Jacobi CE, van den Bos G. Poor and good health outcomes in rheumatoid arthritis: the role of comorbidity. J Rheumatol. 2006; 33:1488–95.

Fig. 1.
Regional distribution of the Hanyang RA cohort.
jkra-16-204f1.tif
Table 1.
Sociodemographic characteristics of the Hanyang RA cohort
  Total (n=1,645) Men (n=196, 11.9%) Women (n=1,449, 88.1%)
Age (yrs) (mean±SD) 51.6±12.4 54.7±13.1 51.2±12.2
Marriage status
 Single 111 (6.91%) 14 (7.29%) 97 (6.86%)
 Married 1,299 (80.8%) 171 (89.06%) 1,128 (79.77%)
 Widowed 153 (9.53%) 4 (2.08%) 149 (10.54%)
 Divorce/Separate 43 (2.68%) 3 (1.56%) 40 (2.83%)
Monthly income (US$)
 <1,000 390 (25.93%) 44 (24.44%) 346 (26.13%)
 1,000∼2,000 405 (26.93%) 49 (27.22%) 356 (26.89%)
 2,000∼3,000 329 (21.88%) 36 (20.00%) 293 (22.13%)
 3,000∼4,000 197 (13.1%) 26 (14.44%) 171 (12.92%)
 ≥4,000 183 (12.7%) 25 (13.89%) 158 (11.93%)
Education (yrs) (mean±SD) 10.2±4.5 Employment duration (month) 205.8±163.4
Last educational background   Occupation  
 No education 121 (7.5%)  Unemployed 318 (19.6%)
 Elementary school graduate 360 (22.4%)  Housewife 786 (48.5%)
 Middle school graduate 261 (16.2%)  Muscular laborer 45 (2.8%)
 High school graduate 506 (31.5%)  Skilled laborer 44 (2.7%)
 College graduate 325 (20.20%)  Salesman 124 (7.7%)
 Higher college graduate 35 (2.2%)  Office worker 125 (7.7%)
   Professional worker 38 (2.3%)
   Etc. 140 (8.6%)
Table 2.
Details related to smoking
  Items T, Number (%) M, Number (%) W, Number (%)
Smoking history Never 1,344 (83.2) 28 (14.51) 1,316 (92.55)
 (T=1,615, M=193, W=1,422) Ex-smoker 149 (9.2) 91 (47.15) 58 (4.08)
  Smoking 122 (7.6) 74 (38.34) 48 (3.38)
Exposure to passive smoking Yes 495 (30.8) 51 (27.42) 444 (31.29)
 (T=1,605, M=186, W=1,419) No 1,110 (69.2) 135 (72.58) 975 (68.71)
Exposure to passive smoking ≤3 days a week 88 (21.5) 3 (18.75) 85 (21.63)
 at home (T=409, M=16, W=393) >3 days a week 321 (78.5) 13 (81.25) 308 (78.37)
Exposure to passive smoking at the ≤3 days a week 34 (26.6) 10 (25.64) 24 (26.97)
 work place (T=128, M=39, W=89) >3 days a week 94 (73.4) 29 (74.36) 65 (73.03)

T: total, M: men, W: women

Table 3.
Clinical characteristics of the Hanyang RA cohort
Variables Total number   Number (%)
Functional disorder and hobbies 1,615 Doesn't interfere with daily life, work ability 366 (22.70)
Unable to perform hobby, but doesn't interfere with daily life 405 (25.10)
Unable to work, but daily life is possible 446 (27.60)
Unable to perform duties of daily life 398 (24.60)
Joint replacement 1,535 No 1,377 (89.71)
Yes 158 (10.29)
Number of joint replacement operations (percentage for total RA patients) 158 1 51 (3.32)
2 93 (6.06)
3 9 (0.59)
4 4 (0.26)
5 1 (0.07)
Site of joint replacement operation (including overlapping operations) (percentage of total RA patients) 158 THR 79 (4.76)
TKR 187 (11.26)
TER 16 (0.96)
TSR 3 (0.18)
RF 1,645 Positive 1,469 (89.30)
Negative 176 (10.70)
Radiographic severity 1,639 Stage 1 353 (21.54)
Stage 2 569 (34.72)
Stage 3 486 (29.65)
Stage 4 231 (14.09)
K-HAQ 1,604 0.9±0.6 (0∼2.88)  
K-INDEX (pain) 1,588 44.1±26.9 (0∼100)  
Age at onset (yrs) 1,641 41.0±12.9 (5∼80)  
Duration of disease (months) 1,620 126.1±103.2 (0∼597)  
Duration of treatment (months) 1,621 103.4±90.9 (0∼1,305)  
Age at initiation of treatment (yrs) 1,641 42.9±12.7 (5∼83)  
Duration from disease onset to initiation of treatment (months) 1,643 23.6±57.1 (0∼444)  

Stage 1, 2, 3 and 4 according to the radiologic criteria of Steinbrocker, et al. Stage 1 (early) RA was defined as the absence of destructive changes on radiographs, stage 2 (moderate) RA was radiographic evidence of osteoporosis, with or without slight subchondral bone destruction or slight cartilage destruction, stage 3 (severe) RA was radiographic evidence of cartilage and bone destruction, subluxation, or ulnar deviation, and stage 4 (terminal) RA was fibrous or bony ankylosis (7). THR: total hip replacement, TKR: total knee replacement, TER: total elbow replacement, TSR: total shoulder replacement, RF: rheumatoid factor, K-HAQ: K-Health assessment questionnaire, RA: rheumatoid arthritis

Table 4.
Summary of the genetic studies for the subjects in the Hanyang RA cohort
RA associated genes Patients/ Controls Allele or SNP Allele frequency (patients/controls) OR (95% CI) p-value Association among ethnic groups (Korean/Caucasian/Japanese)
HLA-DRB1 (manuscript in revision) 1,482/1,119 ∗0405 22.8/8.0 3.41 (2.86∼4.07) 2.42×10−46 (+/+/+)
∗0901 14.1/9.2 1.83 (1.53∼2.19) 4.37×10−11  
∗0401 1.7/0.7 2.75 (1.53∼4.93) 4.26×10−4  
PTPN22 (3) 1,128/1,022 rs2476601 0/0 Monomorphic (−/+/−)
PADI4 (9) 545/392 rs11203366 0.48/0.38 1.5 (1.2∼1.8) 2.3×10−5 (+/−/+)
rs11203367 0.48/0.38 1.5 (1.2∼1.8) 2.3×10−5  
rs874881 0.48/0.38 1.5 (1.2∼1.8) 2.1×10−5  
rs1748033 0.41/0.34 1.4 (1.1∼1.7) 1.1×10−5  
STAT4 (10) 1,123/1,008 rs7574865 0.39/0.33 1.27 (1.11∼1.45) 4.0×10−4 (+/+/+)
rs11889341 0.35/0.3 1.27 (1.12∼1.45) 3.0×10−4  
rs8179673 0.39/0.34 1.22 (1.07∼1.38) 2.0×10−3  
rs10181656 0.39/0.34 1.21 (1.07∼1.37) 2.9×10−3  
TRAF1-C5 (11) 1,316/1,006 rs7021206 0.30/0.26 1.21 (1.06∼1.38) 0.0037 (+/+/+)

SNP: single nucleotide polymorphism, OR: odds ratio, CI: confidence interval, RA: rheumatoid arthritis

TOOLS
Similar articles